Cogent Biosciences, Inc. - Common Stock (NQ:COGT)

29.52 +0.01 (+0.03%)

Delayed Quote Updated: 4:00 PM EDT, Oct 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cogent Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Analyst Expectations for Cogent Biosciences's Future ↗

August 30, 2023

Via Benzinga

Unpacking Blueprint Medicines' Ayvakit's Bright Future: Insights From Latest Physician Survey On Sales Predictions ↗

August 21, 2023

Needham slightly increased the price target for Blueprint Medicines Corp (NASDAQ: BPMC) from $65 to $66

Via Benzinga

$10M Bet On GameStop? Check Out These 3 Stocks Insiders Are Buying ↗

June 14, 2023

Although US stocks closed higher on Tuesday, there were a few notable insider trades.

Via Benzinga

9 Analysts Have This to Say About Cogent Biosciences ↗

June 12, 2023

Via Benzinga

Calavo Growers, Mondee Holdings And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

June 07, 2023

U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Recap: Cogent Biosciences Q1 Earnings ↗

May 09, 2023

Cogent Biosciences (NASDAQ:COGT) reported its Q1 earnings results on Tuesday, May 9, 2023 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Analyst Ratings for Cogent Biosciences ↗

April 28, 2023

Via Benzinga

Expert Ratings for Cogent Biosciences ↗

March 27, 2023

Via Benzinga

4 Analysts Have This to Say About Cogent Biosciences ↗

March 27, 2023

Via Benzinga

What 4 Analyst Ratings Have To Say About Cogent Biosciences ↗

January 05, 2023

Via Benzinga

Why Couchbase Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

June 07, 2023

Gainers Mobiquity Technologies, Inc. (NASDAQ: MOBQ) shares gained 124% to $0.3325. Mobiquity Technologies launched ElecAlytics, an AI-Powered analytics suite added to its ElecTech platform for...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 28, 2023 ↗

April 28, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022 ↗

December 14, 2022

Via Benzinga

Pinterest To Rally Around 23%? Here Are 10 Other Price Target Changes For Tuesday ↗

December 13, 2022

Via Benzinga

Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday's Mid-Day Session ↗

December 12, 2022

Gainers HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share.

Via Benzinga

Cogent Biosciences Touts Positive Data From Bezuclastinib Study In Mastocytosis Patients ↗

December 12, 2022

Via Benzinga

This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday ↗

August 18, 2022

Gainers

Via Benzinga

Denbury, Global-e Online And Agilent Among Top Gainers On Wednesday ↗

August 18, 2022

U.S. stocks closed lower on Wednesday, with the Dow Jones dropping around 170 points. Here is the list of some big stocks moving higher in the previous session.

Via Benzinga

Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day Session ↗

August 17, 2022

Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 79.5% to $4.57 after the company announced it plans to explore the potential development of a novel monkeypox vaccine using its norovirus...

Via Benzinga

Do You Have Biotech FOMO? It Might Be Time To Pay Attention To These Names ↗

July 06, 2022

Biotech stocks continued going gangbusters Wednesday. Here's why, experts say.

Via Investor's Business Daily

Do You Have Biotech FOMO? Why Cogent, Arvinas And Others Are Flying ↗

July 06, 2022

Biotech stocks continued going gangbusters Wednesday. Here's why, experts say.

Via Investor's Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2022 ↗

June 28, 2022

Upgrades

Via Benzinga

89 Biggest Movers From Friday ↗

June 21, 2022

Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy.

Via Benzinga

Cboe's Weekly Market Recap: June 6th To 10th ↗

June 15, 2022

Exciting developments occurred on the Cboe Global Markets Inc. (BATS: CBOE) this week.

Via Benzinga

91 Biggest Movers From Friday ↗

June 13, 2022

Gainers RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto.

Via Benzinga

Mid-Afternoon Market Update: Dow Drops Over 600 Points; Fulcrum Therapeutics Shares Tumble ↗

June 10, 2022

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 600 points on Friday.

Via Benzinga

Cogent Biosciences (COGT) Stock Soars 90% on Positive Clinical Data ↗

June 10, 2022

Today, investors in Cogent Biosciences and COGT stock have some promising clinical trial results to look at, as this stock soars.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Intraday Session ↗

June 10, 2022

Via Benzinga

Why Shares Of Cogent Biosciences Are Trading Higher ↗

June 10, 2022

Cogent Biosciences, Inc. (NASDAQ: COGT) shares are trading higher after the company reported initial data from its ongoing Phase 2 APEX clinical trial.

Via Benzinga

Mid-Day Market Update: Nasdaq Dips 400 Points; Cogent Biosciences Shares Jump ↗

June 10, 2022

U.S. stocks traded lower midway through trading, with the Nasdaq Composite tumbling around 400 points on Friday.

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.